Gabapentin Capsule
Product Images NDC 87441-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 87441-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 100 mg (8744103401 Gabapentin 100 mg)

Gabapentin 100 mg (8744103401 Gabapentin 100 mg)
This text contains information about Gabapentin capsules, USP with a dosage range of 100mg to 800mg. The medication is for prescription use only, and it is advised to dispense it at room temperature between 59°F to 86°F. The packaging insert and Medication Guide should be provided to each patient separately. The medication should be kept in a child-resistant container and away from children. The repackaging was done by Unit Dose Solutions, INC., and the distribution is by Tuckahoe Enterprises, LLC with addresses in Raleigh, NC and Henrico, VA.*
FDA Label Image

Formula (Gabapentin Capsules Usp 1)

Formula (Gabapentin Capsules Usp 1)
This formula calculates the estimated creatinine clearance rate based on the age and weight of the patient. It also adjusts the result for female patients by multiplying the serum creatinine level by 0.85.*
FDA Label Image

Chem Structure (Gabapentin Capsules Usp 2)

FDA Label Image

10 (Gabapentin Capsules Usp 3)

10 (Gabapentin Capsules Usp 3)
This text appears to be a list of medications and dosages. It mentions "Gabapentin, 3500 mg/day" for "Moan Pain Score" for a duration of "Weeks." The purpose or context of the information provided is not fully clear.*
FDA Label Image

10 (Gabapentin Capsules Usp 4)

FDA Label Image

10 (Gabapentin Capsules Usp 5)

10 (Gabapentin Capsules Usp 5)
This text provides information about the proportion of responders in patients with over 50% reduction in pain score in controlled studies related to post-herpetic neuralgia (PHN). The figure reveals data from Study 1 and Study 2, involving different treatments such as GBP 3600, PBO, GBP 150, and GBP 2400.*
FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.